Alternative Splicing and Transcript Isoform Analysis

  • Alternative splicing is an important biological process in which a single pre-messenger RNA (pre-mRNA) molecule can be processed in different ways to produce multiple mature messenger RNA (mRNA) transcripts. These different transcripts, known as transcript isoforms, may contain different combinations of exons and untranslated regions. Alternative splicing increases the functional diversity of genes by allowing one gene to produce multiple RNA molecules and, in many cases, different protein products. It plays important roles in cellular development, tissue differentiation, metabolism, immune responses, environmental adaptation, and disease processes. Bioinformatics approaches are essential for identifying, quantifying, comparing, and interpreting alternative splicing events using large-scale transcriptomic data.
  • In eukaryotic organisms, protein-coding genes commonly contain exons and introns. Exons are sequences retained in mature RNA, whereas introns are generally removed during RNA processing. After transcription, the pre-mRNA undergoes splicing, in which the spliceosome recognizes specific splice sites and removes introns before joining the selected exons. The spliceosome is a molecular complex composed of small nuclear ribonucleoproteins (snRNPs) and associated proteins. Splicing is regulated by cis-regulatory RNA sequences and trans-acting splicing factors that influence which splice sites are selected. These regulatory mechanisms allow cells to produce different transcript isoforms from the same gene.
  • Several major types of alternative splicing occur in eukaryotic genes. Exon skipping, also called cassette exon splicing, occurs when an exon is included in some transcripts but excluded in others. Alternative 5′ splice-site selection changes the beginning of an exon, while alternative 3′ splice-site selection changes its end. Intron retention occurs when an intron remains in the mature transcript rather than being removed. Mutually exclusive exons are alternative exons in which one is included while another is excluded. Alternative first exons and alternative last exons can also produce transcript variants with different transcription start sites, termination regions, or untranslated regions. These events may affect protein sequence, protein localization, stability, translation efficiency, and gene regulation.
  • Alternative splicing can produce substantial changes in protein structure and function. If an alternative exon contains a coding sequence, its inclusion or exclusion may add or remove amino acids, alter a protein domain, modify an active site, or affect protein–protein interactions. Some isoforms may contain premature termination codons and become targets of nonsense-mediated mRNA decay (NMD), a cellular surveillance mechanism that degrades certain abnormal or regulatory transcripts. Other transcript isoforms may differ mainly in their 5′ or 3′ untranslated regions (UTRs), influencing mRNA stability, localization, translation, and interactions with regulatory molecules such as microRNAs. Not every alternative transcript produces a stable or functional protein; some are present at low abundance or are rapidly degraded.
  • Alternative splicing is regulated by several molecular mechanisms. Cis-regulatory elements within pre-mRNA include exonic splicing enhancers, exonic splicing silencers, intronic splicing enhancers, and intronic splicing silencers. These sequences influence the recognition of splice sites by the splicing machinery. Trans-acting factors include serine/arginine-rich (SR) proteins and heterogeneous nuclear ribonucleoproteins (hnRNPs), which can promote or suppress the use of particular splice sites. Their activity may be influenced by phosphorylation, cellular signalling, transcription rate, chromatin structure, and environmental conditions. Mutations in splice sites or regulatory sequences can disrupt normal splicing and contribute to genetic disorders and other diseases.
  • Transcript isoform analysis aims to identify the different RNA transcripts produced from genes and determine their relative abundance across samples or experimental conditions. Traditional gene-level expression analysis estimates the total expression of a gene by combining reads assigned to its transcripts. However, gene-level measurements may overlook important differences in transcript composition. Two samples can show similar total expression of a gene while expressing substantially different transcript isoforms. Transcript-level analysis therefore provides additional information about the regulation and functional diversity of genes.
  • RNA sequencing (RNA-seq) is one of the principal technologies used to investigate alternative splicing and transcript isoforms. In conventional short-read RNA-seq, RNA molecules are converted into cDNA and sequenced into relatively short fragments. These reads are mapped to a reference genome or transcriptome to identify the transcripts from which they originated. Reads spanning exon–exon junctions provide evidence of splicing patterns, while reads within exons contribute to transcript abundance estimates. Because many transcripts share exons, short reads may not always distinguish closely related isoforms accurately. This is an important limitation when several transcripts have similar structures or differ only in a small region.
  • Long-read sequencing technologies provide complementary information by sequencing much longer RNA-derived molecules. Platforms such as Oxford Nanopore Technologies and Pacific Biosciences can generate reads that span multiple exons or, in some cases, nearly complete transcripts. These data can help identify full-length transcript structures, alternative exon combinations, previously unannotated isoforms, and complex splicing patterns. Long-read sequencing is particularly useful for resolving transcripts that cannot be reliably reconstructed from short reads. However, researchers must consider sequencing error profiles, read depth, transcript coverage, library preparation biases, and the need for accurate transcript identification and quantification.
  • A typical alternative splicing analysis workflow begins with RNA sample preparation and sequencing quality control. Raw sequencing reads are examined using tools such as FastQC and MultiQC. Adapter sequences and low-quality bases may be removed using Cutadapt or fastp. Reads are then aligned to a reference genome using splice-aware aligners such as STAR and HISAT2, which can identify reads spanning exon–exon junctions. Alignment files are processed and evaluated to assess mapping quality, coverage, and junction support. Transcript structures are subsequently reconstructed or quantified using suitable transcriptome analysis tools.
  • Several bioinformatics tools are available for transcript assembly and isoform quantification. StringTie can assemble transcripts from RNA-seq alignments and estimate their expression levels. Scallop is another transcript assembler designed to reconstruct transcript structures from short-read sequencing data. Cufflinks is an earlier transcript assembly and quantification tool, although newer workflows often use more recent alternatives. Salmon and kallisto perform transcript-level abundance estimation using efficient mapping-based or pseudoalignment approaches. These tools can estimate transcript abundance without requiring conventional full read alignment, although their accuracy depends on the quality and completeness of the reference transcriptome.
  • Transcript abundance is commonly expressed using transcript per million (TPM), fragments per kilobase of transcript per million mapped fragments (FPKM), or related measures. TPM accounts for transcript length and sequencing depth, allowing relative abundance comparisons within a sample. However, transcript quantification is affected by shared exons, transcript similarity, sequencing depth, and reference annotation. Estimates should therefore be interpreted with their uncertainty, particularly when distinguishing transcripts with highly overlapping structures.
  • Alternative splicing analysis also involves identifying and quantifying specific splicing events. Tools such as rMATS (replicate Multivariate Analysis of Transcript Splicing) identify differential alternative splicing events between experimental conditions using RNA-seq data with biological replicates. SUPPA2 estimates alternative splicing events and their changes using transcript expression measurements. MAJIQ identifies local splicing variations and models complex combinations of splice junctions, while LeafCutter detects differential intron usage without requiring complete transcript reconstruction. Whippet provides a fast approach for analysing alternative splicing and other RNA processing events. These tools use different statistical models and definitions of splicing events, so their results may not be directly interchangeable.
  • One important measurement in alternative splicing analysis is percent spliced in (PSI), also known as the inclusion level. PSI estimates the proportion of transcripts in which a particular exon or splicing event is included rather than excluded. For a simple exon-skipping event, it can be represented as:
  • PSI = Inclusion-supporting reads / (Inclusion-supporting reads + Exclusion-supporting reads)
  • Plain-text formula:
  • PSI = Inclusion-supporting reads /
  •       (Inclusion-supporting reads + Exclusion-supporting reads)
  • Here, inclusion-supporting reads provide evidence that the alternative exon is retained, while exclusion-supporting reads provide evidence that the exon is skipped. PSI ranges from 0 to 1, or can be expressed as a percentage from 0% to 100%. A higher PSI indicates greater inclusion of the exon, while a lower PSI indicates greater exclusion. In practical analyses, PSI calculations may require normalization for the number and length of supporting junctions, event structure, and read coverage. Different software packages may use different definitions and estimation procedures.
  • Differential alternative splicing analysis compares splicing patterns between biological conditions, such as healthy and diseased tissues, treated and untreated samples, or different developmental stages. A commonly used measurement is the difference in percent spliced in:
    • ΔPSI = PSI(condition 1) − PSI(condition 2)
  • A positive ΔPSI indicates increased inclusion in condition 1 relative to condition 2, while a negative value indicates reduced inclusion. Researchers commonly combine ΔPSI with statistical significance and adjusted p-values to identify reliable differential splicing events. The interpretation must consider read coverage, biological variability, sample size, and the statistical model used.
  • Differential transcript usage (DTU) is closely related to alternative splicing analysis but focuses on changes in the relative abundance of transcripts produced by a gene. A gene may maintain approximately the same total expression while the proportions of its transcript isoforms change between conditions. Conversely, a gene may show a change in total expression without a substantial change in transcript composition. Distinguishing differential gene expression from differential transcript usage is important because they represent different aspects of gene regulation. Tools such as DEXSeq, DRIMSeq, satuRn, and IsoformSwitchAnalyzeR can support analyses of exon usage, transcript usage, and isoform switching.
  • Isoform switching occurs when the predominant transcript of a gene changes between biological conditions. For example, one transcript may be most abundant in healthy tissue, while another becomes dominant in diseased tissue. Such changes may affect protein domains, signal peptides, transmembrane regions, subcellular localization, and functional sites. Isoform switching can therefore provide information about biological regulation that is not captured by gene-level expression analysis. IsoformSwitchAnalyzeR supports the investigation of transcript switches and their potential functional consequences, including changes in coding potential and protein features.
  • Functional interpretation of transcript isoforms is an important part of alternative splicing research. Researchers can examine whether isoforms differ in their coding sequences, protein domains, functional motifs, signal peptides, transmembrane regions, and predicted structural properties. Tools such as TransDecoder can help identify candidate coding regions in assembled transcripts, while InterProScan can identify protein families and functional domains. UniProt provides curated protein information, and Pfam and InterPro support the identification of conserved protein domains. Comparing predicted protein products helps determine whether alternative splicing may alter the biological properties of a gene product.
  • Alternative splicing can also influence gene regulation through transcript stability and degradation. Isoforms containing premature termination codons may be targeted by nonsense-mediated decay, reducing the abundance of transcripts that could otherwise produce truncated proteins. Alternative 3′ UTRs can change the availability of microRNA-binding sites and RNA-binding protein recognition sequences, affecting transcript stability and translation. Alternative 5′ UTRs may influence ribosome recruitment and translational efficiency. Consequently, transcript isoform analysis can reveal regulatory mechanisms that extend beyond changes in protein-coding sequences.
  • Alternative splicing is important in many diseases, including cancer, neurological disorders, cardiovascular conditions, and inherited genetic diseases. Abnormal splice-site selection may produce dysfunctional proteins, alter tumour-related signalling pathways, or disrupt normal cellular differentiation. Cancer-associated splicing changes can affect cell growth, apoptosis, metabolism, immune regulation, and drug resistance. Some genetic disorders result from mutations that disrupt normal RNA splicing, while other variants influence regulatory sequences and alter the relative abundance of transcript isoforms. Analysis of these changes can help identify disease-associated transcripts, potential biomarkers, and possible therapeutic targets.
  • In animal genomics and quantitative genetics, alternative splicing contributes to the molecular mechanisms underlying economically important and adaptive traits. Differences in transcript isoforms may influence muscle development, growth rate, feed efficiency, milk composition, fertility, immune function, and environmental adaptation. For example, alternative splicing of genes involved in muscle development may affect protein structure and muscle growth. Isoform variation in immune-related genes may influence responses to infectious diseases, while transcript differences in metabolic genes may contribute to variation in nutrient utilization and production efficiency. Investigating these mechanisms can improve understanding of the genetic regulation of complex traits across livestock breeds and populations.
  • Alternative splicing can also contribute to tissue-specific and developmental regulation. The same gene may produce different transcript isoforms in muscle, liver, brain, reproductive tissues, or immune cells. Isoform composition may also change during embryonic development, growth, puberty, pregnancy, lactation, ageing, and responses to environmental stress. These differences are important when selecting biological samples and interpreting RNA-seq results. Tissue composition and cell-type proportions can influence observed splicing patterns, making cell-type-specific analysis or single-cell RNA sequencing useful in some research settings.
  • Single-cell RNA sequencing (scRNA-seq) provides an opportunity to investigate gene expression and RNA processing at the individual cell level. It can reveal differences in transcript expression among cell populations and help identify cell-type-specific splicing patterns. However, many single-cell protocols capture only part of each transcript and produce relatively sparse sequencing data, which can limit isoform-level resolution. Long-read single-cell approaches and combined short-read and long-read strategies are being developed to improve the identification of full-length transcript isoforms within individual cells.
  • Several technical and analytical challenges affect alternative splicing and transcript isoform analysis. Short-read sequencing may not provide sufficient information to reconstruct complete transcripts, especially when genes contain many exons or share similar sequences. Low transcript abundance, incomplete annotation, sequencing errors, mapping ambiguity, and uneven coverage can affect isoform identification and quantification. Different analysis tools may produce different results because they use different algorithms, event definitions, filtering criteria, and statistical models. Batch effects, tissue heterogeneity, and insufficient biological replication may also produce misleading findings.
  • Experimental validation is important for confirming computationally identified splicing events. RT-PCR and gel electrophoresis can be used to examine alternative exon inclusion and exclusion. RT-qPCR with isoform-specific primers can quantify selected transcript variants, while Sanger sequencing of PCR products can confirm exon–exon junctions and transcript structures. Long-read sequencing can provide additional evidence about complete transcript structures. Protein-level validation may be performed using isoform-specific antibodies, Western blotting, or mass spectrometry when suitable distinguishing protein features are available. Functional experiments may be required to determine whether an isoform change produces a meaningful biological effect.
  • Reliable alternative splicing analysis requires careful experimental design, appropriate statistical methods, and transparent reporting. Researchers should document sample numbers, biological replicates, tissue sources, sequencing platforms, read lengths, reference genome versions, transcript annotation releases, software versions, and analysis parameters. Differential splicing results should include event or transcript identifiers, PSI values, ΔPSI, read coverage, statistical significance, and adjusted p-values where applicable. Reporting the specific reference transcriptome and annotation is particularly important because transcript identifiers and structures may change between database releases.
  • Alternative splicing and transcript isoform analysis provide an important extension of conventional gene expression analysis. While gene-level analysis describes how much a gene is expressed, transcript-level analysis reveals which RNA isoforms are produced and how their relative abundance changes across biological conditions. Integrating short-read and long-read RNA sequencing, transcript quantification, differential splicing analysis, functional annotation, and experimental validation provides a more complete understanding of gene regulation. These approaches are increasingly valuable in molecular biology, disease research, biotechnology, agriculture, animal breeding, and functional genomics.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *